Home
About Us
In 2025, the number of innovative drug BD transactions in China was quite impressive, accounting for about one - third of the total global BD transactions.
In the past few years, we have invested in more than 30 Chinese innovative pharmaceutical companies and reached BD transactions with more than 10 companies.
The impact of the BD transactions of secondary - market companies on their stock prices needs to be analyzed in combination with the actual situation of the companies.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Social Entrepreneurship
Spotlight
Connecting Investors with CDFIs to Support Community Impact
CNote is a women-led impact investment platform that uses technology to unlock diversified and proven community investments that increase economic mobility and financial inclusion.
